SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-045119
Filing Date
2011-02-24
Accepted
2011-02-24 14:46:21
Documents
10
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 VIROPHARMA INCORPORATED - FORM 10-K d10k.htm 10-K 1430409
2 VIROPHARMA BOARD COMPENSATION POLICY dex1010.htm EX-10.10 10469
3 SECOND AMENDED AND RESTATED BULK MATERIAL SUPPLY AGREEMENT dex1050.htm EX-10.50 155033
4 AMENDED AND RESTATED BULK MATERIAL SUPPLY AGREEMENT dex1051.htm EX-10.51 12177
5 FORM OF RESTRICTED SHARE UNIT AWARD AGREEMENT dex1052.htm EX-10.52 24986
6 LIST OF SUBSIDIARIES dex21.htm EX-21 4992
7 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 2895
8 SECTON 302 CEO CERTIFICATION dex311.htm EX-31.1 9552
9 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9544
10 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 4645
  Complete submission text file 0001193125-11-045119.txt   1666068
Mailing Address 730 STOCKTON DRIVE EXTON PA 19341
Business Address 730 STOCKTON DRIVE EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

IRS No.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21699 | Film No.: 11635688
SIC: 2834 Pharmaceutical Preparations